Circular Genomics
PrivateLast Round
Series A
Dec 1, 2025
Total Funding Raised
$28.05M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Circular Genomics is a biotechnology company that develops circular RNA-based diagnostic assays and precision medicine tools for psychiatric and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Mental Health
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Circular Genomics Comparables
Compare Circular Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindX Sciences | 87% | |
| Pax Neuroscience | 79% | |
| ALCEN | 78% | |
Circular Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2025 | ||||
| Grant | Jul 8, 2025 | ||||
| Series A | Jan 24, 2024 | ||||
| Seed | Dec 14, 2021 |
Key People
Founding team and executive leadership
Circular Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UNM Rainforest Innovations | Series A |
| Cottonwood Technology Fund | Series A, Seed |
| Mountain Group Partners | Seed, Series A |
| HIP Fund | Series A |
| Tramway Venture Partners | Series A, Seed |
| Alzheimer's Drug Discovery Foundation | Series A, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Co-developing Alzheimer's detection workflow with Vitazi.ai.
- Apr 29, 2026
Partnered with Vitazi.ai for Alzheimer's disease detection workflow.
Circular Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Circular Genomics's valuation, stock price, and market status.